RxDoctor Payments Data

Mahmoud Khairy

Cardiovascular Disease · Lansing, MINPI 1134573181

Payments from drug & device makers

$6,386in general payments, 2019–2025

Across 72 payments — averaging $88.70 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Abbott$4K
  • E.r. Squibb & Sons, L.L.C.$382
  • AstraZeneca$261
  • Amgen$259
  • Pfizer$210
  • Alnylam Pharmaceuticals Inc.$188
  • plus $937 from 14 others

What the payments were for

  • Grants$4,15065%
  • Food & beverage$2,23635%

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$6,386 in reported general payments places this provider in the 60th percentile of 760 cardiovascular disease providers in Michigan.

See all cardiovascular disease providers in Michigan

Most prescribed under Part D

DrugClaimsCost to plans & patients
Rosuvastatin Calcium14$504
Metoprolol Succinate19$374
Atorvastatin Calcium25$370
Metformin Hcl11$112
Amlodipine Besylate14$110

Paid to pharmacies, not to this prescriber.

Other cardiovascular disease in Lansing

See the full list for Michigan

Where these figures come from

Is this you, or does something look wrong? →